Increase Access to Human Papillomavirus (HPV) Vaccination

Increase access to human papillomavirus (HPV) vaccination.

Access to GARDASIL HPV Vaccine

"MSD (Merck) is pursuing a systematic and thoughtful approach to expanding access to GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] in the developing world including a number of initiatives to study the public health impact of routine vaccination programs and to accelerate the introduction of vaccines in resource-poor countries.

In May 2010, Bhutan became the first developing nation in the world to implement a national cervical cancer vaccination program. MSD partnered with the government of Bhutan and the Australian Cervical Cancer Foundation (ACCF) to initiate a six-year program aimed at reducing incidences of the disease. The program, led by the Bhutan Ministry of Health, provided an opportunity for eligible girls and young women between the ages of 12 and 18 to be vaccinated with GARDASIL as part of this initiative. This partnership to provide HPV vaccination to all eligible girls completed its fourth successful year in 2013.

In April 2011, and through collaboration between the government of Rwanda, MSD and QIAGEN, the Rwanda Ministry of Health a launched a comprehensive national cervical cancer prevention program. Approximately 90,000 Rwandan girls were vaccinated with GARDASIL in the first year of the program, and, over the three-year program, Rwanda was supplied with enough doses to vaccinate over 450,000 girls.

In September 2012, the Republic of Uganda, through the Ministry of Health (MoH) and supported by MSD, launched a sub-national vaccination program with GARDASIL. Through this agreement, the vaccination program was implemented with nearly 500,000 doses of GARDASIL donated to 12 districts in Uganda, enough to vaccinate approximately 160,000 girls age 9 to 13 of age over a two year period. The program represented the first phase of Uganda’s national roll-out plan for human papillomavirus (HPV) vaccination.

Through the GARDASIL Access Program, launched in 2007, MSD has donated over 1.2 million doses of MSD's HPV vaccine to support the development of successful immunization programs in lowest income nations. The program has enabled applicants in 21 countries to gain operational experience in designing and implementing small-scale HPV vaccination projects. From Africa to Asia and Latin America, these experiences provided helpful information about the feasibility of HPV vaccine delivery in developing country settings. While vaccine doses are no longer being awarded, experiences and lessons learned are being disseminated in an effort to contribute to the public knowledge base on HPV vaccine access and child and adolescent immunization models.

*MSD is known as Merck in the U.S. and Canada"


  • Merck

    Goods Supplier, Service Providers
    United States | Staff size: 10,000+

    Merck is an innovative, global healthcare leader that is committed to improving health and well-being around the world. At Merck, they're applying their global reach, financial strength and...

  • Indian Council of Medical Research (ICMR)

    Staff size: 101-250

    The Indian Council of Medical Research (ICMR), New Delhi, the apex body in India for the formulation, coordination and promotion of biomedical research, is one of the oldest medical research...

  • Rwanda Ministry of Health

    Rwanda | Staff size: Unknown

    The main goal of the Ministry of Health is to provide and continually improve the health services of the Rwandan population through the provision of preventive, curative and rehabilitative...

  • Qiagen

    Goods Supplier
    Germany | Staff size: 1001-5000

    QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample & Assay Technologies that are used to transform biological materials into valuable molecular...

  • Uganda Ministry of Health

    Uganda | Staff size: 251-500

    The Ministry of Health Uganda, is a government body set up with the mandate of policy formulation and policy dialogue with Health Development Partners, resource mobilization and budgeting,...

  • PATH

    Implementing NGO
    United States | Staff size: 501-1000

    They dare to believe that innovation can change the world

    PATH is the leader in global health innovation. An international nonprofit organization, they save lives and improve health,...

More Resources

Key Information

LocationEast Asia and Pacific, Viet Nam, Vanuatu, Uzbekistan, Uganda, Tanzania, Peru, Papua New Guinea, Nicaragua, Nepal, Moldova, Lesotho, Kenya, India, Haiti, Ghana, Georgia, Cameroon, Cambodia, Bolivia, Bhutan, West Africa, Southern Africa, South Asia, Latin America and Caribbean, Eastern Africa, Central Asia, Central Africa
  • Start Date 2005